Ultralife Corp. (NASDAQ:ULBI) was the target of a significant decrease in short interest in July. As of July 15th, there was short interest totalling 179,900 shares, a decrease of 11.3% from the June 30th total of 202,900 shares. Currently, 1.8% of the company’s stock are sold short. Based on an average daily volume of 54,400 shares, the short-interest ratio is currently 3.3 days.
NASDAQ:ULBI opened at $7.10 on Friday. Ultralife has a one year low of $4.85 and a one year high of $10.00. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.36 and a current ratio of 3.89. The firm has a market cap of $115.02 million, a price-to-earnings ratio of 21.52 and a beta of 1.36. The firm’s fifty day moving average is $6.84 and its two-hundred day moving average is $7.01.
Ultralife (NASDAQ:ULBI) last posted its quarterly earnings results on Thursday, April 30th. The technology company reported $0.08 EPS for the quarter. Ultralife had a net margin of 4.64% and a return on equity of 5.92%. The company had revenue of $25.81 million for the quarter.
Several research firms recently issued reports on ULBI. ValuEngine downgraded Ultralife from a “buy” rating to a “hold” rating in a research report on Tuesday, April 21st. TheStreet downgraded Ultralife from a “b-” rating to a “c+” rating in a research report on Friday, July 10th.
In other news, Director Bradford T. Whitmore bought 5,000 shares of the business’s stock in a transaction that occurred on Thursday, May 14th. The shares were purchased at an average cost of $7.43 per share, with a total value of $37,150.00. Following the transaction, the director now directly owns 563,902 shares in the company, valued at $4,189,791.86. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Bradford T. Whitmore bought 5,534 shares of the business’s stock in a transaction that occurred on Monday, May 4th. The stock was purchased at an average cost of $7.64 per share, for a total transaction of $42,279.76. Following the completion of the transaction, the director now owns 544,436 shares in the company, valued at $4,159,491.04. The disclosure for this purchase can be found here. Over the last ninety days, insiders have bought 22,022 shares of company stock worth $170,095. Insiders own 38.40% of the company’s stock.
A number of large investors have recently bought and sold shares of the business. Teton Advisors Inc. boosted its holdings in Ultralife by 23.6% in the first quarter. Teton Advisors Inc. now owns 182,000 shares of the technology company’s stock valued at $946,000 after purchasing an additional 34,800 shares during the last quarter. Cambridge Investment Research Advisors Inc. purchased a new stake in shares of Ultralife during the 1st quarter worth about $55,000. Finally, Marshall Wace North America L.P. purchased a new stake in shares of Ultralife during the 1st quarter worth about $36,000. 35.11% of the stock is currently owned by institutional investors.
Ultralife Company Profile
Ultralife Corporation designs, manufactures, installs, and maintains power, and communication and electronic systems for government, defense, and commercial sectors worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium ion cells, multi-kilowatt module lithium ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.
Further Reading: Return On Assets
Receive News & Ratings for Ultralife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultralife and related companies with MarketBeat.com's FREE daily email newsletter.